The National Pharmaceutical Council's research helps to inform many critical health care policy debates and supports the organization's overall goal of achieving the best patient outcomes in the most efficient way possible. Over the years, the issues we have focused on have evolved along with the changes in the health care environment and pharmaceutical industry. NPC’s current research examines the most pressing topics in comparative effectiveness research (CER), individual treatment effects, and the optimal role and value of pharmaceuticals in emerging payment and delivery models.

This study provides an early evaluation of the CER Collaborative's training program's impact on learners’ self-reported abilities to Read More
The National Pharmaceutical Council led a study that identified three principles intended to maximize the positive aspects and minimize the Read More
This study captures the policy inconsistencies and hurdles that can hinder use of publicly funded federal and state datasets for Read More